Join
Live feed
·
PRReleasevia Quantisnow
Horizon Technology Finance Corporation logo

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

ByQuantisnow·Wall Street's wire, on your screen.
HRZN· Horizon Technology Finance Corporation
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HRZN (Horizon Technology Finance Corporation) and more on Quantisnow.